Are CNTA, WSR, GDOT Obtaining Fair Deals for their Shareholders?
Centessa Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Centessa Pharmaceuticals plc - CNTA
38,432 Shares in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA Acquired by B. Metzler seel. Sohn & Co. AG
Here Are Monday’s Top Wall Street Analyst Research Calls: Adobe, Best Buy, Bilibili, Constellation Brands, CoreWeave, Nike, Starbucks, T-Mobile, and More
Are APLS, CNTA, KZR Obtaining Fair Deals for their Shareholders?
Shareholder Alert: The Ademi Firm investigates whether Centessa Pharmaceuticals plc is obtaining a Fair Price for Public Shareholders
Centessa Pharmaceuticals (NASDAQ:CNTA) Reaches New 1-Year High – What’s Next?
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Centessa Pharmaceuticals plc (NASDAQ: CNTA)
LLY to Buy Neuroscience Biotech Centessa Pharmaceuticals in $7.8B Deal
Here Are Wednesday’s Top Wall Street Analyst Research Calls: Boeing, Datadog, Disney, Formula One Group, Nike, Rivian, Rocket Lab, ServiceNow, and More
Centessa Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Centessa Pharmaceuticals plc - CNTA
Why Centessa Stock Soared Today
Nxera Pharma’s Partner Centessa Pharmaceuticals to be Acquired by Lilly
Options Traders Pick Up Pharma Stock After Eli Lilly Buyout
Eli Lilly stock rises after $7.8B Centessa deal—bet on sleep drugs
Shareholder Alert: The Ademi Firm investigates whether Centessa Pharmaceuticals plc is obtaining a Fair Price for Public Shareholders
Dow Eyes Worst Month Since 2022 Despite Last Minute Flourish
Are APLS, CNTA, BIRD Obtaining Fair Deals for their Shareholders?
Eli Lilly to acquire Centessa in $6.3B deal to expand neuroscience portfolio
Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs
Why Eli Lilly Is Buying Centessa for $7.8 Billion
CNTA Stock Alert: Halper Sadeh LLC is Investigating Whether Centessa Pharmaceuticals plc is Obtaining a Fair Price for its Shareholders
Eli Lilly to acquire Centessa in $6.3B deal to expand neuroscience portfolio
Eli Lilly to Buy Centessa Pharmaceuticals for Initial $6.3 Billion
Eli Lilly to buy Centessa Pharma in $6.3 billion deal
Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
Karen Anderson Sells 41,076 Shares of Centessa Pharmaceuticals (NASDAQ:CNTA) Stock
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Receives Consensus Recommendation of “Buy” from Brokerages
Insider Selling: Centessa Pharmaceuticals (NASDAQ:CNTA) Insider Sells $1,927,250.68 in Stock
Centessa Pharmaceuticals Teases ORX750 Phase II Update, Registrational Study Start at Conference
Nxera Pharma to Receive US$3 Million Milestone Payment from Centessa Pharmaceuticals
Biotech Fund Dumps 1.85 Million Centessa Shares as Stock Jumps Over 50%
This Fund Just Disclosed a New $55 Million Bet on Centessa Amid 53% Stock Rally and CEO Transition
Nxera Pharma to Receive $1.8 Million Milestone Payment from Centessa Pharmaceuticals
Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
This Fund Locked In Gains With a $14.5 Million Biotech Exit Amid a Staggering Stock Rally
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Receives Consensus Rating of “Moderate Buy” from Analysts
Centessa Pharmaceuticals Announces Poster Presentation of New Preclinical Data Supporting Expansion of Orexin Receptor 2 (OX2R) Agonist Pipeline into Neuropsychiatric Indications at the 64th ACNP Annual Meeting
Nxera Pharma to Receive US$3.6 Million in Milestone Payment Pursuant to Research Collaboration with Centessa
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Given Average Rating of “Moderate Buy” by Brokerages
Critical Review: Centessa Pharmaceuticals (NASDAQ:CNTA) & Universe Pharmaceuticals (NASDAQ:UPC)
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Receives Consensus Recommendation of “Buy” from Analysts
Centessa Pharmaceuticals Announces CEO Transition as Company Advances Strategy to Extend Orexin Leadership into Multiple Neuroscience Indications
What One Fund's Sale of Centessa Stock Signals About the Fast-Rising Biotech Company
Campbell & CO Investment Adviser LLC Acquires New Position in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA
Centessa Stock Has Surged 77% Over the Past Year — But a Top Biotech Fund Is Still Buying
Why Centessa Pharmaceuticals Stock Crushed the Market Today
Centessa Pharmaceuticals Announces Pricing of $250,000,000 Public Offering of American Depositary Shares
Centessa Pharmaceuticals Announces Proposed Public Offering of American Depositary Shares
Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences